A phase II study of oral fluorouracil for gastrointestinal cancer

Anti-Cancer Drugs

Volumn 7, Issue 1, 1996, Pages 48-53

  Cartei, F ^a   Cartei, G ^a   Giraldi, T ^a   Interlandi, G ^a   Meneghini, G ^a   Imperato, A ^a   Vigevani, E ^a   Tabaro, G ^a  

^a SANTA MARIA DELLA MISERICORDIA UNIVERSITY HOSPITAL   (Italy)

Author keywords

Gastrointestinal cancer; Oral 5 fluorouracil

Indexed keywords

FLUOROURACIL; FOLINIC ACID; LOPERAMIDE; MANNITOL; METHYLPREDNISOLONE; METOCLOPRAMIDE; MORPHINE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COLORECTAL CANCER; DIARRHEA; DIGESTIVE SYSTEM CANCER; DRUG EFFICACY; ERYTHEMA; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LIVER CANCER; MALE; NAUSEA; ORAL DRUG ADMINISTRATION; PANCREAS CANCER; PRIORITY JOURNAL; QUALITY OF LIFE; SOMNOLENCE; STOMACH CANCER; STOMATITIS;

EID: 0030062382     PISSN: 09594973     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001813-199601000-00005     Document Type: Article

References (0)